M&A / Deals Lilly, AI biotech Profluent ink $2.25B pact in search of genetic medicine ‘holy grail’ pharminent April 28, 2026
Regulatory FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss Under National Priority Voucher Program pharminent April 23, 2026
